Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 August 2021 | Story ANDRÉ DAMONS | Photo ANDRÉ DAMONS
Dr Osayande Evbuomwan, a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, always wanted to specialise in an area of medicine that was novel, innovative, intriguing and involved a lot of opportunities for groundbreaking research

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS) always wanted to specialize in an area of medicine that was novel, innovative, intriguing and involved many opportunities for groundbreaking research.

This passionate medical man, who joined the UFS in 2019, is behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer. 
The UFS and the Free State province can now join other South African universities, like the University of Pretoria, University of the Witwatersrand, and other provinces in using this method to treat MCRPC patients. 

Built for this job

Dr Evbuomwan explains nuclear medicine is a medical specialty that involves the use of unsealed sources of radiation in the form of radioisotopes for the diagnosis and treatment of various disease conditions including cancers.
“It’s novelty and opportunity for research and ability to diagnose and treat disease conditions in one specialty attracted me to this field. I always wanted to be a doctor. I see it as a calling. It was also something my mum discovered while I was growing up as a child. In my next life, I would choose to be a medical doctor again,” he says.

“I was built for this job and it is always my joy to have the opportunity to carry out my work. We have been well-trained for this; we support all our skills with prayers. We try to give our patients the very best,” says Dr Evbuomwan, who is originally from Benin City, Edo state, Nigeria. 

After graduating as a nuclear medicine specialist from Wits University, Dr Evbuomwan moved to the City of Roses after a work opportunity opened. He saw it as an opportunity to showcase his talents.

“I have been privileged to receive training in this treatment during my residency training at Wits. I treated a few of these patients during my training and the results were amazing. The University of Pretoria has also been involved with this treatment, with some amazing results that are recognised worldwide. 

“This was enough to convince me to push for our department to also join the powerhouses and offer this treatment to patients who need it. With the influence of a very understanding head of department, Dr Gerrit Engelbrecht, we have been successful in pushing for the commencement of this treatment at our facility,” says Dr Evbuomwan.

Important treatment
According to him, the availability and expertise of Lutetium 177 PSMA (Lu-177 PSMA) therapy to treat MCRPC is very important for the Free State and the UFS, as it is able to offer an option for patients who do not qualify for available conventional treatment and/or who have failed the first line of conventional treatment. 

“In the majority of patients this treatment offers improved quality of life, disease-free progression and improved overall survival. It also alleviates the constant bone pains these patients have to go through daily. To be able to offer this treatment puts the university and the province on the map alongside other top institutions in and outside the country. It also offers opportunity for research,” says Dr Evbuomwan.

He believes with a PET/CT camera for proper staging of these patients with cancer the UFS would be able to expand the treatment of patients suffering from this deadly illness. Currently the university does not possess such a camera and has to use lesser methods in identifying the right patients for this therapy.

News Archive

University recognised as leading Higher Education Institution for students with disabilities
2013-12-05

The University of the Free State has been lauded for creating an inclusive environment for persons with disabilities, winning the 2013 National Disability Higher Education Institution Award. The award was presented at the National Disabilities Awards held in Port Elizabeth as part of the celebrations for International Day of People with Disabilities.

The Deputy Minister for Women, Children and People with Disabilities, Hendrietta Ipeleng Bogopane-Zulu, commended the university during the event for standing out among South African institutes of higher education. She told the audience the award gives recognition to institutions that demonstrate, through their strategy and policy, the provision of an inclusive environment for persons with disabilities. This is done through the use of technology and accessibility at their premises.

It's not the first time the university received praise from the deputy minister. In 2012 she visited the Bloemfontein Campus as part of a nation-wide roadshow to assess disability compliance and support services at all universities and FET colleges. Impressed with the work of the Unit for Students with Disabilities (USD), she recommended that staff from various higher education institutions visit the campus to gain insight into what they are doing.

Receiving the award on behalf of the university, Hetsie Veitch, Director of the USD, says the award recognises the commitment of the university’s senior leadership, who support the USD in creating a learning environment that is welcoming and accessible to all students.

Rudi Buys, Dean of Student Affairs, says the university is appreciative of what the USD does and says the award is a great achievement for a unit that only started functioning on its own three years ago. “The role of our support unit for Students with Disabilities has since 2010 grown to hold not only a prominent place in our institutional reflection on and implementation of approaches of universal access, but also to stand as leading department in building and bearing witness to the commitment of the UFS to values of universal access.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept